BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ireland G, Delpech V, Kirwan P, Croxford S, Lattimore S, Sabin C, Porter K, Mandal S, Simmons R. Prevalence of diagnosed HIV infection among persons with hepatitis C virus infection: England, 2008-2014. HIV Med 2018;19:708-15. [PMID: 30051565 DOI: 10.1111/hiv.12662] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Anh NT, Hong NTT, Nhu LNT, Thanh TT, Anscombe C, Chau LN, Thanh TTT, Lau CY, Limmathurotsakul D, Chau NVV, Rogier van Doorn H, Deng X, Rahman M, Delwart E, Le T, Thwaites G, Van Tan L; Southeast Asia Infectious Disease Clinical Research Network. Detection and Characterization of Human Pegivirus 2, Vietnam. Emerg Infect Dis 2018;24:2063-7. [PMID: 30334714 DOI: 10.3201/eid2411.180668] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Hallager S, Lundh A, Ladelund S, Gerstoft J, Laursen AL, Clausen MR, Balslev U, Weis N. The Prevalence of Human Immunodeficiency Virus Coinfection Among Patients Newly Diagnosed With Chronic Hepatitis B or C in Denmark: A Nationwide Cohort Study. Open Forum Infect Dis 2018;5:ofy310. [PMID: 30581882 DOI: 10.1093/ofid/ofy310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kwan TH, Wong BCK, Wong KH, Lee SS. Hepatitis C Co-infection in People Living With HIV—Epidemiologic Differences Between Men Who Have Sex With Men MSM and Non-MSM. Front Public Health 2022;10:925600. [DOI: 10.3389/fpubh.2022.925600] [Reference Citation Analysis]
4 Ali S, Ur-Rehman T, Lougher E, Mutimer D, Ali M, Paudyal V. Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug-drug interactions and hepatitis C cure. Int J Clin Pharm 2020;42:515-26. [PMID: 32100238 DOI: 10.1007/s11096-020-00994-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ahmadi Gharaei H, Fararouei M, Mirzazadeh A, Sharifnia G, Rohani-Rasaf M, Bastam D, Rahimi J, Kouhestani M, Rezaian S, Dianatinasab M. The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis. Infect Dis Poverty 2021;10:93. [PMID: 34210349 DOI: 10.1186/s40249-021-00876-7] [Reference Citation Analysis]
6 McLeod A, Hutchinson SJ, Smith S, Leen C, Clifford S, McAuley A, Wallace LA, Barclay ST, Bramley P, Dillon JF, Fraser A, Gunson RN, Hayes PC, Kennedy N, Peters E, Templeton K, Goldberg DJ. Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study. HIV Med 2021;22:334-45. [PMID: 33350049 DOI: 10.1111/hiv.13032] [Reference Citation Analysis]
7 Binka M, Butt ZA, McKee G, Darvishian M, Cook D, Wong S, Yu A, Alvarez M, Samji H, Wong J, Krajden M, Janjua NZ. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada. Int J Infect Dis 2021;106:246-53. [PMID: 33771673 DOI: 10.1016/j.ijid.2021.03.061] [Reference Citation Analysis]